Renal endpoints in renal and cardiovascular randomized clinical trials: time for a consensus?
Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Bruno Giraudeau(Inserm), Bénédicte Sautenet(Université de Tours), Philippe Gatault(Centre Hospitalier Universitaire de Tours), Mélanie Roland(Centre Hospitalier Universitaire de Tours)
Cited by 14
Related Papers
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2)
|The Lancet|2017|568
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
|JAMA|2020|518
Hydrocortisone in Severe Community-Acquired Pneumonia
|New England Journal of Medicine|2023|438
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228